ATP Testing for Healthcare Facilities:
How RLU Benchmarks Replace the Honor System

How does ATP testing verify that healthcare cleaning actually happened?

Every living cell runs on ATP. Adenosine triphosphate is the energy currency of biology. Bacteria carry it. Blood carries it. Mucus, skin cells, food residue, all of it carries ATP. When a surface is poorly cleaned, that residue stays behind. ATP testing detects it.

The mechanism is the luciferin-luciferase reaction, the same bioluminescence chemistry that makes fireflies glow. A swab contacts the surface, is activated with the luciferin-luciferase reagent, and the luminometer reads the light emission produced when the reagent reacts with whatever ATP is present. The result is a single number: Relative Light Units. The reaction and the read take 10 to 15 seconds. No incubation. No lab. No 48-hour wait for culture results.

The RLU value is a proxy for biological burden, not a pathogen identification. A surface with an RLU above threshold has enough organic residue that you cannot confirm the disinfectant reached the actual surface material. A surface below threshold was cleaned thoroughly enough that residue is below the level correlated with significant microbial load.

That distinction matters. I have been in facilities where the infection prevention team was satisfied with ATP results below 100 RLU on bed rails but had never asked what product was used or whether the contact time was observed. ATP verifies cleaning thoroughness. It does not verify that the right disinfectant was used at the right dwell time. Both legs of the program need to hold.

What RLU threshold counts as a passing read for healthcare surfaces?

This is where most conversations about ATP go sideways. There is no single universal pass number. The most cited reference is Mulvey et al., Journal of Hospital Infection, 2011. That study established a correlation between 100 RLU and under 2.5 CFU per square centimeter on the NHS Scotland standard. NHS Scotland adopted 100 RLU as its operational benchmark for general hospital surfaces. That number has become the de facto industry reference in the U.S. as well.

But 100 RLU is not the right threshold for every surface in every setting. ICUs, transplant units, and operating rooms typically use 45 to 63 RLU. The Methodist Specialty and Transplant Hospital published a 2024 study using 45 RLU as the inpatient threshold and reported 95 percent weekly pass compliance after baseline calibration. High-touch surfaces in those environments, bed rails, call buttons, IV poles, tray tables, need tighter thresholds than a waiting room chair.

Outpatient medical offices and ambulatory clinics commonly use 200 RLU as an alert threshold and 500 RLU as a fail. The CDC and manufacturers including Hygiena and PDI explicitly state that no single benchmark fits all surfaces, materials, and use patterns. A defensible ATP program documents its thresholds by zone, surface type, and cleaning frequency. It includes the rationale. When your surveyor asks why you use 63 RLU in the ICU, the answer should not be "that's what someone told us."

Note: Thresholds above represent common published ranges and should be adapted to your facility-specific cleaning frequency, surface materials, and risk zone classification. Publish your facility thresholds in writing before running your first audit cycle.

Why did the SHINE trial change the conversation about ATP in healthcare?

Before 2022, the argument for ATP testing in healthcare was mostly theoretical. You could show that low RLU correlated with low microbial counts, and you could argue that clean surfaces reduce pathogen transmission. But no randomized trial had directly tied an ATP monitoring program to a reduction in actual infection rates in a real ICU population.

The SHINE trial changed that. Anderson et al., published in Clinical Infectious Diseases in 2022, ran a cluster-randomized crossover trial across six ICUs at three U.S. academic medical centers. The intervention was real-time feedback to EVS staff on ATP results and cleaning performance. The comparator was UV/fluorescent marker monitoring with similar feedback.

Results: ATP monitoring produced a statistically significant reduction in MDRO incidence. Incidence rate ratio 0.876, 95 percent CI 0.807 to 0.951, P=.002. In plain terms, ICUs using ATP feedback had 12.4 percent fewer multidrug-resistant organism acquisitions than ICUs using fluorescent marker feedback. The fluorescent marker arm produced no statistically significant reduction.

The mechanism is what matters. ATP monitoring gave EVS staff a number immediately after cleaning. That number either confirmed the clean or triggered a retraining event on the spot. Fluorescent markers require a UV light and a separate walkthrough after cleaning. They do not catch the quality of the disinfection. They catch whether a surface was wiped. ATP catches whether the wipe actually worked.

One more number from the SHINE trial that does not get cited often enough. Room turnaround time impact: ATP monitoring added one additional minute to room turnaround. Fluorescent marker monitoring added 4.5 additional minutes. The clinically superior method was also operationally faster.

How is ATP testing different from fluorescent markers, RODAC plates, and visual inspection?

Four verification methods show up in healthcare EVS programs. They measure different things. They are not interchangeable. Here is what each one actually tells you.

RODAC plates deserve a separate note. Contact agar culture is the most precise method for quantifying microbial contamination. A RODAC plate pressed against a surface and incubated for 24 to 48 hours will tell you exactly how many colony forming units were present. The problem is the 48-hour window. By the time you have the result, the room has had two more patients. RODAC plates are useful for baseline studies, program validation, and outbreak investigation. They are not useful for real-time corrective action.

The right program uses ATP for real-time feedback and spot RODAC sampling for periodic program validation. The two methods are complementary. ATP tells EVS staff whether to reclean before the next patient. RODAC tells the infection prevention committee whether the ATP thresholds are calibrated correctly.

What does an ATP testing program actually cost?

The capital cost is straightforward. A healthcare-grade luminometer, Hygiena SystemSURE Plus, 3M Clean-Trace LM1, or equivalent, runs $1,500 to $3,000 at current pricing. The luminometer is reusable. The ongoing cost is swabs, which run $1 to $3 each at volume pricing depending on the device and swab type.

Here is what that looks like at two facility scales. These are general estimates based on market pricing. They are not quotes.

Many cleaning contractors who operate ATP programs fold the swab cost into the service rate rather than billing it as a line item. If you are evaluating vendors, ask specifically: does the ATP program cost appear in the contract as an included service or as a separate billable? A vendor who bills swabs separately at retail pricing will often cost more annually than one who includes them in the base rate.

The honest context: ATP program cost at a 50-bed hospital is roughly $10,000 to $30,000 per year depending on swab volume and whether you hire program coordination internally or include it in the cleaning contract. Against a single MRSA HAI at $23,301 in direct costs or a single C. diff case at $34,157, the math is not complicated.

How do you run an ATP audit cycle in a Southeast medical facility?

An ATP audit cycle is not a number. It is a loop. Surface sample, result, compare to threshold, corrective action if over threshold, reclean, resample, document. Here is how that works in practice for a Southeast hospital or medical office.

"ATP testing without a published threshold and a documented corrective action loop is theater. The number on the screen is not the program. The audit trail is the program."

Austin Jones, CEO, Millennium Facility Services

What do CDC and Joint Commission actually say about ATP testing?

Neither CDC nor TJC mandates ATP testing by name in their current published guidance. That is often used as a reason not to implement it. It is the wrong conclusion.

The CDC HICPAC Environmental Infection Control Guidelines (MMWR Vol. 52, No. RR-10, 2003, with subsequent updates including the March 2024 supplemental guidance) explicitly state that visual inspection is insufficient as a sole verification method. The CDC Best Practices for Environmental Cleaning in Healthcare Facilities (CS314156-A) recommends an objective monitoring strategy for high-risk patient care areas. ATP bioluminescence is the primary example of an objective, real-time monitoring method. The CDC does not say "use ATP." It says use something that produces objective results. ATP is the tool the industry has built around that recommendation.

Joint Commission's IC.02.01.01 requires facilities to implement and manage their infection prevention and control program. Under the 2024 rewrite, surveyors now move beyond documentation to testing practical implementation. A facility that has only visual inspection as a verification method is likely to draw scrutiny when surveyors ask how the cleaning program is monitored. Facilities with documented ATP programs, threshold definitions, trend data, and corrective action logs are in a stronger position to satisfy IC.02.01.01 under the new survey methodology.

AORN's Guideline for Environmental Hygiene (October 2025) addresses verification of OR cleaning in explicit terms. The guideline recommends objective monitoring methods for terminal cleaning verification. ATP bioluminescence is referenced as an appropriate method. AORN also addresses the documentation requirement: date, time, personnel identity, disinfectant lot, concentration, and verification result on every terminal clean. That verification result should be an ATP reading, not "visually clean."

The documentation surveyors expect to see: ATP pass rates by zone for the prior 90 days, written facility thresholds by surface type, corrective action logs for failures, and staff retraining records tied to specific failure events. A printed report from your data platform, Hygiena SureTrend or 3M Clean-Trace, covers the first three. Your training records system covers the fourth. Facilities that can produce all four in the DNV three-hour document window are in a defensible position. Facilities that can produce none of them are not.

Frequently Asked Questions